跳转至内容
Merck
CN

Y0000136

抑霉唑

European Pharmacopoeia (EP) Reference Standard

别名:

1-[2-(2,4-二氯苯基)-2-(2-丙烯氧基)乙基]-1H-咪唑

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C14H14Cl2N2O
化学文摘社编号:
分子量:
297.18
MDL number:
UNSPSC Code:
41116107
NACRES:
NA.24
PubChem Substance ID:
Beilstein/REAXYS Number:
545683
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI

1S/C14H14Cl2N2O/c1-2-7-19-14(9-18-6-5-17-10-18)12-4-3-11(15)8-13(12)16/h2-6,8,10,14H,1,7,9H2

SMILES string

Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1

InChI key

PZBPKYOVPCNPJY-UHFFFAOYSA-N

grade

pharmaceutical primary standard

API family

enilconazole

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

General description

Enilconazole is a topically active imidazole derivative, for veterinary application in poultry against Aspergillus sp., and in dogs, cattle, and horses for the treatment of dermatophytosis.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Enilconazole may be used as a reference compound to analyze the effect of enilconazole during the surgical treatment of canine nasal aspergillosis by rhinotomy combined with enilconazole infusion and oral itraconazole.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Acute Tox. 4 Inhalation - Aquatic Chronic 1 - Carc. 2 - Eye Dam. 1

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

农药列管产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Surgical treatment of canine nasal aspergillosis by rhinotomy combined with enilconazole infusion and oral itraconazole.
Claeys S, et al.
The Journal of Small Animal Practice, 47(6), 320-324 (2006)
Treatment of canine nasal aspergillosis with enilconazole.
Sharp N J, et al.
Journal of Veterinary Internal Medicine, 7(1), 40-43 (1993)
Liwei An et al.
Antiviral research, 109, 54-63 (2014-06-28)
Infection with influenza A virus is still a global concern since it causes significant mortality, morbidity and economic loss. New burst pandemics and rapid emergence of drug-resistance strains in recent years call for novel antiviral therapies. One promising way to
Vera van Noort et al.
Cancer research, 74(20), 5690-5699 (2014-07-20)
Drug-induced gene-expression profiles that invert disease profiles have recently been illustrated to be a starting point for drug repositioning. In this study, we validate this approach and focus on prediction of novel drugs for colorectal cancer, for which there is

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持